Rapport Therapeutics Inc. Common Stock

9.93
0.67 (7.24%)
At close: Apr 14, 2025, 3:59 PM
9.80
-1.31%
Pre-market: Apr 15, 2025, 05:16 AM EDT

Rapport Therapeutics Common Stock Stock Forecast

Stock Price Forecast

The 5 analysts with 12-month price forecasts for RAPP stock have an median target of 35, with a low estimate of 28 and a high estimate of 42. The median target predicts an increase of 252.47% from the current stock price of 9.93.

Created with Highcharts 11.4.3
Analyst Consensus: Buy
Created with Highcharts 11.4.3Jul 2024Sep 2024Nov 2024Jan 2025Mar 2025May 2025Jul 2025Sep 2025Nov 2025Jan 2026Mar 2026$0$20$40$60

Past 12 Months

12 Month Forecast

Target Low Average Median High
Price $28 $35 $35 $42
Change 181.97% 252.47% 252.47% 322.96%

Latest Analyst Insight Report

Stifel initiated coverage on Rapport Therapeutics ... Unlock content with Pro Subscription

Updated Jul 02, 2024

Created with Highcharts 11.4.3Jul '24Oct '24Apr '2501234
Rating Jul 24Oct 24Apr 25
Strong Buy 000
Buy 310
Hold 000
Sell 000
Strong Sell 000
Total 3 1 0

Financial Forecast this Year

Revenue This Year
n/a
Revenue Next Year
0
from 0
Increased by -%
EPS This Year
-3.56
from -0.38
Increased by -836.8%
EPS Next Year
-4.26
from -3.56
Increased by -19.7%